[1] Wahlstrm A, Sayin SI, Marschall HU,et al. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab, 2016, 24: 41-50.
[2] Attinkara R, Mwinyi J, Truninger K,et al. Association of genetic variation in the NR1H4 gene, encoding the nuclear bile acid receptor FXR, with inflammatory bowel disease. BMC Res Notes, 2012, 5: 461.
[3] Hirschfield GM, Mason A, Luketic V,et al. Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid. Gastroenterology, 2015, 148: 751-761.
[4] Degirolamo C, Sabbà C, Moschetta A. Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23. Nat Rev Drug Discov, 2016,15:51-69. |
